Tarsorrhaphy

Tarsorrhaphy
SpecialtyOphthalmology

Tarsorrhaphy is a surgical procedure in which the eyelids are partially sewn together to narrow the eyelid opening.[1] It may be done to protect the cornea in cases of corneal exposure, as a treatment for proptosis (eye protrusion), for example, Graves' ophthalmopathy, Möbius syndrome and other conditions which cause eyelid paralysis. It is also done to allow or promote corneal healing in cases of corneal injuries and lesions.[2] The procedure is performed on the corner of the eyelid opening.[3] Tarsorrhaphy may be temporary or permanent.[2]

The most common technique for tarsorrhaphy is to partially suture the eyelids, however in some cases the procedure may be performed by partially gluing the eyelids using cyanoacrylate glue,[4] injections of botulinum toxin can be administered to paralyze the upper lid levator muscle, or attaching a weight, often made of gold, to the upper eyelid.[2] The latter technique produces quicker results and immediately improves the quality of life, making it more suitable for patients with cancer.[5]

Complications after surgery include failure to protect ocular or corneal surface, dehiscence, trichiasis, pyogenic granuloma, corneal abrasion, haemorrhage, and infection.[6] In cases of late referral to surgery in patients with thyroid disease, there is an increased risk of corneal ulcers and, consequently, permanent corneal opacity which limited patients' eyesight[7] The vast majority of failed operations have been reported in patients who had ocular surgeries in the past, the rate of failiure is also higher in patients with systemic disorders such as diabetes mellitus and connective tissue disorders.[6]

See also

References

  1. ↑ Beutner, Katherine (2025-04-29). "Tarsorrhaphy: the cornea's best friend". EyeWorld. Retrieved 2025-09-01.
  2. 1 2 3 Gounder, Pav; Selva, Dinesh; Rajak, Saul N. (2022-06-21). "Malignant lesions of the caruncle". Eye. 37 (5): 849–857. doi:10.1038/s41433-022-02124-0. ISSN 0950-222X. PMC 10050163.
  3. ↑ "Tarsorrhaphy". Encyclopedia of Surgery. Archived from the original on 18 April 2015. Retrieved 31 August 2015.
  4. ↑ Donnenfeld, Eric D.; Perry, Henry D.; Nelson, David B. (October 1991). "Cyanoacrylate Temporary Tarsorrhaphy in the Management of Corneal Epithelial Defects". Ophthalmic Surgery, Lasers and Imaging Retina. 22 (10): 591–593. doi:10.3928/1542-8877-19911001-09.
  5. ↑ Tan, Swee T.; Staiano, Jonathan J.; Itinteang, Tinte; McIntyre, Benjamin C.; MacKinnon, Craig A.; Glasson, David W. (April 2013). "Gold weight implantation and lateral tarsorrhaphy for upper eyelid paralysis". Journal of Cranio-Maxillofacial Surgery. 41 (3): e49 – e53. doi:10.1016/j.jcms.2012.07.015.
  6. 1 2 Moura-Coelho, Nuno; Manero, Felicidad; Papa, Renato; Amich, Nicolas; Cunha, João Paulo; Güell, José Luis (2022-01-06). "Photorefractive keratectomy after DMEK for corneal decompensation by phakic IOL". European Journal of Ophthalmology. 33 (3): NP5 – NP8. doi:10.1177/11206721211073429. ISSN 1120-6721.
  7. ↑ Grusha, Y.O.; Ismailova, D.S.; Fettser, E.I. (2021). "Tarsorrhaphy in rehabilitation of patients with thyroid eye disease". Vestnik oftal'mologii. 137 (5): 47. doi:10.17116/oftalma202113705147. ISSN 0042-465X.


This article is issued from WikiProjectMed. The text is available under Creative Commons Attribution-ShareAlike License unless otherwise noted. Additional terms may apply for the media files.